Neuroprotective effects of the SCR1-3 functional domain of CR1 on acute cerebral ischemia and reperfusion injury in rats

Neurological Research

Volumn 35, Issue 9, 2013, Pages 976-983

  Yang, Shaojun ^a   Wang, Xiaoyan ^b   Zhang, Xuan ^a   Lu, Yanzhi ^a   Wang, Zhengqing ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b Chongqing Tuberculosis Prophylactico Therapeutic Institution   (China)

Author keywords

Cerebral ischemia reperfusion injury; Complement; CR1; Inflammation; SCR1 3

Indexed keywords

COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C4B; MALONALDEHYDE; MYELOPEROXIDASE; SUPEROXIDE DISMUTASE; COMPLEMENT RECEPTOR; NEUROPROTECTIVE AGENT;

ADULT; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; COMPLEMENT SYSTEM; CONTROLLED STUDY; DISEASE SEVERITY; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOTOR DYSFUNCTION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; WESTERN BLOTTING; ANIMAL; BRAIN; CEREBRAL ARTERY DISEASE; CHEMISTRY; CONSENSUS SEQUENCE; DRUG EFFECT; ISOLATION AND PURIFICATION; METABOLISM; NEUTROPHIL; PATHOLOGY; PHYSIOLOGY; PROTEIN DOMAIN; RANDOMIZATION; SEVERITY OF ILLNESS INDEX; SPRAGUE DAWLEY RAT;

ANIMALS; BLOTTING, WESTERN; BRAIN; COMPLEMENT C4B; CONSENSUS SEQUENCE; IMMUNOHISTOCHEMISTRY; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MOVEMENT DISORDERS; NEUROPROTECTIVE AGENTS; NEUTROPHILS; PROTEIN INTERACTION DOMAINS AND MOTIFS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, COMPLEMENT; REPERFUSION INJURY; SEVERITY OF ILLNESS INDEX;

EID: 84885654673     PISSN: 01616412     EISSN: 17431328     Source Type: Journal    
DOI: 10.1179/1743132813Y.0000000238     Document Type: Article

References (28)

1. Komotar RJ, Kim GH, Often ML, Hassid B, Mocco J, Sughrue ME, et al. The Role of complement in stroke therapy. Adv Exp Med Biol. 2008;632:23-33.
2. Hill JH, Ward PA. The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats. J Exp Med. 1971;133:885-900.
3. Komotar RJ, Starke RM, Arias EJ, Garrett MC, Otten ML, Merkow MB, et al. The complement cascade: new avenues in stroke therapy. Curr Vasc Pharmacol. 2009;7:287-92.
4. Ducruet AF, Zacharia BE, Hickman ZL, Grobelny BT, Yeh ML, Sosunov SA, et al. The complement cascade as a therapeutic target in intracerebral hemorrhage. Exp Neurol. 2009;219:398-403.
5. De Simoni MG, Rossi E, Storini C, Pizzimenti S, Echart C, Bergamaschini L. The powerful neuroprotective action of C1-inhibitor on brain ischemia-reperfusion injury does not require C1q. Am J Pathol. 2004;164:1857-63.
6. Gesuete R, Storini C, Fantin A, Stravalaci M, Zanier ER, Orsini F, et al. Recombinant C1 inhibitor in brain ischemic injury. Ann Neurol. 2009;66:332-42.
7. Mocco J, Mack WJ, Ducruet AF, King RG, Sughrue ME, Coon AL, et al. Preclinical evaluation of the neuroprotective effect of soluble complement receptor type 1 in a nonhuman primate model of reperfused stroke. J Neurosurg. 2006;105: 595-601.
8. Figueroa E, Gordon LE, Feldhoff PW, Lassiter HA. The administration of cobra venom factor reduces post-ischemic cerebral injury in adult and neonatal rats. Neurosci Lett. 2005;380:48-53.
9. Gorsuch WB, Guikema BJ, Fritzinger DC, Vogel CW, Stahl GL. Humanized cobra venom factor decreases myocardial ischemia-reperfusion injury. Mol Immunol. 2009;47:506-10.
10. Banz Y, Rieben R. Role of complement and perspectives for intervention in ischemia-reperfusion damage. Ann Med. 2012;44:205-17.
11. Yamaguchi A, Takagawa H, Iwakaji H, Miyagawa S, Wang PC, Ishii N. Construction of the plasmid, expression by Chinese hamster ovary cell, purification and characterization of the first three short consensus repeat modules of human complement receptor type 1. J Biochem. 2009;145:533-42.
12. Krych-Goldberg M, Atkinson JP. Structure-function relationships of complement receptor type 1. Immunol Rev. 2001;180: 112-22.
13. Furtado PB, Huang CY, Ihyembe D, Hammond RA, Marsh HC, Perkins SJ. The partly folded back solution structure arrangement of the 30 SCR domains in human complement receptor type 1 (CR1) permits access to its C3b and C4b ligands. J Mol Biol. 2008;375:102-18.
14. Yang S, Zhang X, Wang Z. Cloning, expression of the SCR1-3 domains of human complement receptor type 1 and analysis of its activities. Immunol J. 2012;28:64-8.
15. Li S, Xian J, He L, Luo X, Tan B, Yang Y, et al. The protective effect of SCR(15-18) on cerebral ischemia-reperfusion injury. Neurol Res. 2011;33:866-74.
16. Molnar L, Hegedus K, Fekete I. Reversible experimental middle cerebral artery occlusion. Stroke. 1990;21:679-80.
17. Costa C, Zhao L, Shen Y, Su X, Hao L, Colgan SP, et al. Role of complement component C5 in cerebral ischemia/reperfusion injury. Brain Res. 2006;1100:142-51.
18. Jia YJ, Min LQ, Ji ZS, Liu C. Influence of procyanidin on Bcl-2 and Bax after cerebral ischemia. Chin J Clin Rehabil. 2006;10:65-6z72.
19. Xing B, Chen H, Zhang M, Zhao D, Jiang R, Liu X, et al. Ischemic post-conditioning protects brain and reduces inflammation in a rat model of focal cerebral ischemia/reperfusion. J Neurochem. 2008;105:1737-45.
20. Wagner E, Frank MM. Therapeutic potential of complement modulation. Nat Rev Drug Discov. 2010;9:43-56.
21. Mollnes TE, Kirschfink M. Strategies of therapeutic complement inhibition. Mol Immunol. 2006;43:107-21.
22. Morrison H, Frye J, Davis-Gorman G, Funk J, McDonagh P, Stahl G, et al. The contribution of mannose binding lectin to reperfusion injury after ischemic stroke. Curr Neurovasc Res. 2011;8:52-63.
23. Wang J, Jiang C, Liu C, Li X, Chen N, Hao Y. Neuroprotective effects of progesterone following stroke in aged rats. Behav Brain Res. 2010;209:119-22.
24. Wang W, Xu J, Li L, Wang P, Ji X, Ai H, et al. Neuroprotective effect of morroniside on focal cerebral ischemia in rats. Brain Res Bull. 2010;83:196-201.
25. Huber-Lang M, Sarma JV, Zetoune FS, Rittirsch D, Neff TA, McGuire SR, et al. Generation of C5a in the absence of C3: a new complement activation pathway. Nat Med. 2006;12:682-7.
26. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol. 1982;78:206-9.
27. Chai W, Wang Y, Lin JY, Sun XD, Yao LN, Yang YH, et al. Exogenous hydrogen sulfide protects against traumatic hemorrhagic shock via attenuation of oxidative stress. J Surg Res. 2012;176:210-9.
28. Ansari MN, Bhandari U, Islam F, Tripathi CD. Evaluation of antioxidant and neuroprotective effect of ethanolic extract of Embelia ribes Burm in focal cerebral ischemia/reperfusioninduced oxidative stress in rats. Fundam Clin Pharmacol. 2008;22:305-14.